KSHB: Recent Study Paves Way for Potential Multiple Sclerosis Vaccine
Over the last several decades, the number of people living with multiple sclerosis in the U.S. has more than doubled. Nearly one million Americans are living with the condition and about 200 new cases of MS are diagnosed each week.
A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life. Those who had the virus had a 32x higher risk of developing MS. Because of this study’s results, researchers are now working on developing a potential vaccine for multiple sclerosis in the future.
KSHB spoke to an expert with Saint Luke’s Comprehensive Multiple Sclerosis Center about the study.
Recent News
News
Higher Omega-3 Levels Associated with Improved Mental Health
News
BJC Health Hospitals Named to U.S. News & World Report 2026 Best Hospitals for Maternity Care
News
KCTV: The Importance of Lung Cancer Screenings with Saint Luke’s
News
Media Coverage: NICU at Saint Luke's Hospital in KC Celebrates Opening of 'Wicked: For Good' with Oz-Inspired Costumes
News
KSHB: Kansas City 5-Year-Old Finds Her Voice Through Play Therapy At Saint Luke's
News